GMO Research & AI Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

GMO Research & AI has a total shareholder equity of ¥2.0B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥2.9B and ¥947.0M respectively. GMO Research & AI's EBIT is ¥308.0M making its interest coverage ratio -23.7. It has cash and short-term investments of ¥1.4B.

Anahtar bilgiler

0%

Borç/özkaynak oranı

JP¥0

Borç

Faiz karşılama oranı-23.7x
NakitJP¥1.36b
EşitlikJP¥1.99b
Toplam yükümlülüklerJP¥947.00m
Toplam varlıklarJP¥2.94b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

Aug 22
Investors Can Find Comfort In GMO Research & AI's (TSE:3695) Earnings Quality

GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Aug 07
GMO Research & AI, Inc. (TSE:3695) Investors Are Less Pessimistic Than Expected

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 3695's short term assets (¥2.3B) exceed its short term liabilities (¥930.0M).

Uzun Vadeli Yükümlülükler: 3695's short term assets (¥2.3B) exceed its long term liabilities (¥17.0M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 3695 is debt free.

Borcun Azaltılması: 3695 has not had any debt for past 5 years.

Borç Kapsamı: 3695 has no debt, therefore it does not need to be covered by operating cash flow.

Faiz Kapsamı: 3695 has no debt, therefore coverage of interest payments is not a concern.


Bilanço


Sağlıklı şirketleri keşfedin